SYRE NASDAQ
Spyre Therapeutics, Inc.
1W: -1.8%
1M: +1.8%
3M: +72.0%
YTD: +143.0%
1Y: +382.6%
3Y: +1892.5%
5Y: -60.7%
$74.05
-0.27 (-0.36%)
Weekly Expected Move ±7.0%
$64
$70
$75
$80
$85
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026202
Institutions Holding
+35 vs prior
78.9%
Ownership
+14.24%
49
New
60
Increased
70
Reduced
31
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-08 | HENDERSON MICHAEL THOMAS | director | S-Sale | 19,269 | $75.35 | $1.5M | Filing |
| 2026-05-08 | HENDERSON MICHAEL THOMAS | director | S-Sale | 24,814 | $74.76 | $1.9M | Filing |
| 2026-05-08 | HENDERSON MICHAEL THOMAS | director | S-Sale | 33,513 | $73.72 | $2.5M | Filing |
| 2026-05-08 | HENDERSON MICHAEL THOMAS | director | S-Sale | 2,404 | $72.57 | $174K | Filing |
| 2026-05-01 | Sloan Sheldon | officer: chief medical officer | S-Sale | 10,358 | $73.74 | $764K | Filing |
| 2026-05-01 | Burrows Scott L | officer: chief financial officer | S-Sale | 12,500 | $71.37 | $892K | Filing |
| 2026-05-01 | Sloan Sheldon | officer: chief medical officer | S-Sale | 21,306 | $69.53 | $1.5M | Filing |
| 2026-05-01 | Sloan Sheldon | officer: chief medical officer | S-Sale | 19,656 | $70.61 | $1.4M | Filing |
| 2026-05-01 | Sloan Sheldon | officer: chief medical officer | S-Sale | 8,777 | $71.56 | $628K | Filing |
| 2026-05-01 | Sloan Sheldon | officer: chief medical officer | S-Sale | 12,777 | $72.94 | $932K | Filing |
| 2026-05-01 | Sloan Sheldon | officer: chief medical officer | S-Sale | 5,059 | $74.60 | $377K | Filing |
| 2026-05-01 | Sloan Sheldon | officer: chief medical officer | S-Sale | 400 | $75.37 | $30K | Filing |
| 2026-05-01 | Turtle Cameron | officer: chief executive officer | S-Sale | 5,300 | $69.54 | $369K | Filing |
| 2026-05-01 | Turtle Cameron | officer: chief executive officer | S-Sale | 3,600 | $70.77 | $255K | Filing |
| 2026-05-01 | Turtle Cameron | officer: chief executive officer | S-Sale | 1,000 | $71.76 | $72K | Filing |
| 2026-05-01 | Turtle Cameron | officer: chief executive officer | S-Sale | 3,100 | $73.14 | $227K | Filing |
| 2026-05-01 | Turtle Cameron | officer: chief executive officer | S-Sale | 1,700 | $74.23 | $126K | Filing |
| 2026-05-01 | Turtle Cameron | officer: chief executive officer | S-Sale | 300 | $74.96 | $22K | Filing |
| 2026-04-01 | Turtle Cameron | officer: chief executive officer | S-Sale | 12,344 | $49.20 | $607K | Filing |
| 2026-04-01 | Turtle Cameron | officer: chief executive officer | S-Sale | 2,656 | $49.92 | $133K | Filing |
| 2026-04-01 | Sloan Sheldon | officer: chief medical officer | S-Sale | 7,958 | $50.00 | $398K | Filing |
| 2026-04-01 | Burrows Scott L | officer: chief financial officer | S-Sale | 1,300 | $49.98 | $65K | Filing |
| 2026-04-01 | Burrows Scott L | officer: chief financial officer | S-Sale | 6,200 | $49.21 | $305K | Filing |
| 2026-03-03 | Burrows Scott L | officer: chief financial officer | S-Sale | 200 | $41.66 | $8K | Filing |
| 2026-03-03 | Burrows Scott L | officer: chief financial officer | S-Sale | 2,300 | $40.56 | $93K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 11,781,024 | $594M | +142,205 | 2026-03-31 | Filing |
| BlackRock, Inc. | 5,521,221 | $278M | -880 | 2026-03-31 | Filing |
| RTW INVESTMENTS, LP | 4,171,996 | $210M | — | 2026-03-31 | Filing |
| Fairmount Funds Management LLC | 4,018,101 | $203M | — | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,057,401 | $154M | +3,057,401 | 2026-03-31 | Filing |
| Driehaus Capital Management LLC | 2,790,785 | $141M | -91,635 | 2026-03-31 | Filing |
| STATE STREET CORP | 2,607,031 | $131M | +344,192 | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 1,957,266 | $99M | +490,000 | 2026-03-31 | Filing |
| Commodore Capital LP | 1,912,380 | $96M | -475,865 | 2026-03-31 | Filing |
| TCG Crossover Management, LLC | 1,900,582 | $96M | — | 2026-03-31 | Filing |
| TANG CAPITAL MANAGEMENT LLC | 1,892,200 | $95M | — | 2026-03-31 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 1,824,811 | $92M | +275,527 | 2026-03-31 | Filing |
| Capital International Investors | 1,746,129 | $88M | -1,746,412 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,720,912 | $87M | +61,772 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 1,656,164 | $84M | -172,845 | 2026-03-31 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 1,621,620 | $82M | — | 2026-03-31 | Filing |
| Remedium Capital Partners, LLC | 1,456,231 | $73M | — | 2026-03-31 | Filing |
| Affinity Asset Advisors, LLC | 1,279,134 | $65M | -153,457 | 2026-03-31 | Filing |
| BANK OF AMERICA CORP /DE | 1,228,093 | $62M | +808,366 | 2026-03-31 | Filing |
| FRANKLIN RESOURCES INC | 882,833 | $45M | -226,441 | 2026-03-31 | Filing |